Management of Esophageal Dysmotility Disorders

Viewing Options


Topic Information

Target Audience

Nurse practitioners and physician assistants involved in the management of patients with GI disorders and chronic liver disease.

Goal Statement

The primary goal of the educational activity is to encourage the application of the latest advances in evidence-based medicine to improve the quality of care and improve outcomes for the patients affected by thrombocytopenia.

Educational Objectives

At the conclusion of this activity, participants will be able to:

Discuss the benefits and limitations of key surgical for esophageal motility disorders

Discuss the safety and efficacy of key medical treatment options for esophageal motility disorders

Release Date: 11/30/19
Expiration Date: 11/30/20   
*This program has expired. CME credit is no longer available.

ANCC Accreditation

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

A maximum of 0.5 contact hours may be earned for successful completion of this activity.

AANP Accreditation:

This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Annenberg Center for Health Sciences and GI Health Foundation. Annenberg Center for Health Sciences is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207.

This program is accredited for 0.5 contact hours. Program ID #5742

AAPA Accreditation:

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid for one year from 11/30/2019. PAs should only claim credit commensurate with the extent of their participation.

Disclosure of Conflicts of Interest:

Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

The opinions expressed during the on demand activity are those of the faculty and do not necessarily represent the views of the Annenberg Center for Health Sciences at Eisenhower. The information is presented for the purpose of advancing the attendees' professional development.

Staff at the Annenberg Center for Health Sciences at Eisenhower and the GI Health Foundation have no relationships to disclose.

Learner Assurance Statement:

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Faculty Disclosures:

Gwen Cassidy, APN, MSN
Employee: Northwestern Medicine

This activity is supported by educational grants from: AbbVie, AMAG Pharmaceuticals, American Regent, Gilead, Intercept Pharmaceuticals, Mallinckrodt Pharmaceuticals, Pfizer Inc., Prometheus Laboratories Inc., Salix Pharmaceuticals and Takeda.

Accredited by

© Copyright 2013-2021 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.